Effects of cannabinoids on brain development in adolescents
Impact of Cannabinoid Across the Lifespan (ICAL)
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA-IRVINE · NIH-11120988
This study looks at how using THC, a part of cannabis, during teenage years can change brain development and behavior, helping us understand the risks of cannabis use for young people and involving students and the community in the process.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA-IRVINE (nih funded) |
| Locations | 1 site (IRVINE, UNITED STATES) |
| Trial ID | NIH-11120988 on ClinicalTrials.gov |
What this research studies
This research investigates how exposure to THC, a component of cannabis, during adolescence affects brain development and behavior. It aims to understand the long-term changes in the endocannabinoid system that may lead to addiction and other behavioral issues. The study involves various scientific activities, including workshops and training programs, to educate and involve students and the community. By examining these effects, the research seeks to provide insights into the risks associated with cannabis use in young people.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who may have been exposed to THC or are at risk of cannabis use.
Not a fit: Patients who are not within the age range of 12 to 20 or those who have not been exposed to THC may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention strategies for cannabis-related addiction and behavioral disorders in adolescents.
How similar studies have performed: Previous research has shown significant effects of cannabinoids on brain development, indicating that this area of study is both relevant and critical.
Where this research is happening
IRVINE, UNITED STATES
- UNIVERSITY OF CALIFORNIA-IRVINE — IRVINE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PIOMELLI, DANIELE — UNIVERSITY OF CALIFORNIA-IRVINE
- Study coordinator: PIOMELLI, DANIELE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: addictive disorder